Adamas Pharmaceuticals Inc (ADMS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 3,856,000 $18,509 +41% 0.42%
2.
Stonepine Capital

Timothy P. Lynch

3,418,279 $16,408 +323% 8.86%
3. 2,210,743 $10,611 +153% 2.23%
4.
Opaleye Management

James A. Silverman

1,670,600 $8,019 +13% 1.17%
5. 812,612 $3,901 -10% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.06 5,975 Director 15,975 2021-03-11 Filing
$12.98 3,850 Officer, Director 199,242 2018-11-07 Filing
$16.81 8,240 Large Shareholder, Director 4,031,804 2016-09-16 Filing
$16.50 200 Large Shareholder, Director 4,023,564 2016-09-15 Filing
$16.43 54,537 Large Shareholder, Director 4,023,364 2016-09-14 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.17 2,000 Director 8,000 2021-06-07 Filing
$5.50 1,051 Officer 169,435 2021-03-22 Filing
$5.48 2,422 Officer 145,017 2021-03-22 Filing
$6.36 3,821 Officer 72,439 2021-02-01 Filing
$6.39 4,514 Officer 95,486 2021-02-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 5,130,723 $24,627 0%
2. 2,200,200 $10,561 0.29%
3. 1,717,484 $8,244 0%
4. 800,100 $3,840 1.08%
5. 549,010 $2,635 0%
News See All